I agree with most of what you're saying there are many many companies that had and still have great ideas for treatments for Covid and other viruses but unfortunately the sector fizzled out 2 years ago and there are hundreds of companies with undeveloped and unproven products that will likely never see the light of day because they ran out of popularity and money
You see a lot of scams on the OTC. Signs are companies with no products, no services, no employees, no revenue, no money, etc.
The fact that Todos has product like Tollovid and Tollovir doesn't fit your scam scenario. How did they complete a successful phase II trial with Tollovir? Did Todos pay off everyone involved, hirer actors and smuggle them into the hospital?
How did they get Tollovid on the market?
Why is Tollovid working for some Covid and Long Covid sufferers?
Why are some Long Covid clinics working with Todos?
Lastly, why doesn't that order for 50,000 shares @ 007 ever get filled?
Todos is a high risk/high reward stock like a lot of other microcap stocks and even private startups. Not everyone's bucket of oats.
the Todos Isreali connection speaks to their law firm and their connections oversea's as to the structuring of this security - and you can bet your bottom dollar, this security and its backers will continue to suck this dry - all the while posturing for a 3CL Protease acquirer to come in with as much $$$ while risking little to none of their own - know this routine all too well from Gerald's previous failed venture - watch for the pom-poms - they're enforce too...!
News 
Market Data 
Discover 
